PRODUCTS

..............................................................

PRE-QUALIFIED HUMAN CELLS

PURE CARDIOMYOCYTES

.

LABORATORY SERVICES

..............................................................

CONTRACT ASSAY SERVICES

CONTRACT RESEARCH

ASSAY DESIGN & DEVELOPMENT

OPTIONAL ON-SITE SERVICES

.

EDUCATIONAL SERVICES

..............................................................

SUMMARY OF EDUCATIONAL SERVICES

.

CONSULTING

..............................................................

SUMMARY OF CONSULTING SERVICES

..............................................................

 

What's New

 

ReachBio is now the exclusive North American distributor for Axiogenesis AG.  Initial products consist of Cor.AT® pure cardiomyocytes for drug development, cardiotoxicity, hypertrophy and electrophysiology applications.

 

:: more info

 

..............................

 

CONFERENCES

 

Society of Toxicology (SOT), Booth and Exhibitor Hosted Seminar

 

Molecular Medicine Tri Conference Booth Exhibit

 

 

 

 

Home > Contract Assay > In Vivo Assays > Quantification of Stem Cells

 

Quantification of Stem Cells in NOD/SCID Model

 

The NOD/SCID mouse system is a powerful tool to assess true stem cell number and functional behavior. Although in vitro assays such as Colony Forming Cell (CFC) assays are extremely useful in enumerating and analyzing hematopoietic and non-hematopoietic progenitors, the acid test for true stem cells is their ability to reconstitute the entire blood forming system of an ablated host. The NOD/SCID mouse is an immunodeficient recipient, which allows the introduction of human cells and the determination of stem cell functionality through engraftment, proliferation and differentiation into at least two distinct lineages (typically myeloid and lymphoid). This in vivo reconstitution assay is typically known as the Competitive Repopulating Unit (CRU) or SCID Repopulating Cell (SRC) assay.

 

ReachBio can perform CRU/SRC assays with NOD/SCID mice to:

 

  • Quantify true stem cell numbers in test and control samples of human cells

  • Determine the effect of test compounds on engraftment potential of human stem cell samples

  • Quantify functional stem cell numbers in expanded cell populations

 

ReachBio’s comprehensive service using the in vivo NOD/SCID model (CRU/SRC assays) includes:

  • Initial consultation with Study Director*

  • Assay selection and design (including cell type/number selection)

  • Study execution

  • Data interpretation

  • Full written report

  • Follow-up consultation

  • Full confidentiality

 

Please contact us to discuss your needs.

 

* ReachBio Study Directors are highly knowledgeable and have many years of experience in the scientific and practical aspects of CRU/SRC assays.

 

 

 © ReachBio LLC    All Rights Reserved

 

1 206 420 0300  |